Biotech stocks have struggled as a group, but the pace of drug discovery is accelerating. In this episode of “The Angle,” Sal Rais joins Jennifer Martin to explore how new ways of treating disease are improving human health and how breakthrough drugs can create value for some biotech innovators.
Passive investment strategies enjoyed a long period of growth in the era of low rates, ample liquidity, and low volatility that followed the global financial crisis. However, in the new world of higher rates, greater dispersion, and heightened volatility, the need for active investment strategies will increase.
Our insights show you what’s ahead, what’s most important, and how our investment teams are responding now - so you have the full picture.
Register or sign in as an institutional investor or consultant to tailor your preferences.
Hear directly from our experts on timely themes and topics.
202507-4687954